R&D

GSK suffers another R&D setback, axing ulcerative colitis drug trial
Pharmaforum
Mon, 01/25/21 - 10:58 am
GSK
ulcerative colitis
R&D
GSK2831781
Tracking cancer metastasis with CRISPR opens new areas for drug development
Fierce Biotech
Sat, 01/23/21 - 11:41 pm
cancer
metastasis
CRISPR
R&D
GlaxoSmithKline's Immutep-partnered midstage GI med culled in ulcerative colitis
Fierce Biotech
Fri, 01/22/21 - 10:37 am
GSK
R&D
IMMUTEP
ulcerative colitis
Pfizer's R&D president Dolsten: Not taking government cash made us more nimble for COVID-19 vaccine
Fierce Biotech
Fri, 01/22/21 - 10:36 am
Pfizer
R&D
vaccines
COVID-19
JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping
Fierce Pharma
Wed, 01/13/21 - 12:13 am
JPMHC 2021
COVID-19
pandemic
R&D
drug marketing
David Ricks
Stephane Bancel
Pharma CEOs
JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how pharma works
Fierce Biotech
Tue, 01/12/21 - 11:04 am
JPMHC 2021
pandemic
Novartis
COVID-19
R&D
Rocket Pharmaceuticals announces buildout of R&D and manufacturing facility to support development of gene therapy pipeline
Pharmaceutical Business Review
Tue, 01/12/21 - 10:54 am
Rocket Pharmaceuticals
drug manufacturing
R&D
New Jersey
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genetic Engineering News
Wed, 01/6/21 - 11:27 pm
Genentech
Roche
Ribometrix
small molecule drugs
drug discovery
R&D
Fast-expanding Shanghai Pharma breaks ground on $1.8B biotech park focused on next-gen R&D, antibody production
Endpoints
Mon, 01/4/21 - 10:23 am
China
Shanghai Pharmaceutical
R&D
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
MedCity News
Mon, 12/28/20 - 10:43 am
COVID-19
R&D
drug development
cancer
oncology
2021 forecast: COVID-19 brings infectious disease R&D out of the wilderness
Fierce Biotech
Tue, 12/22/20 - 10:44 am
infectious diseases
R&D
COVID-19
Former J&J VP sues pharma giant, accusing top execs of discriminating, harassing and retaliating against her
Endpoints
Fri, 12/18/20 - 11:44 am
JNJ
R&D
gender discrimination
Janux pairs up with Merck for $1B-plus T-cell engager deal
Fierce Biotech
Fri, 12/18/20 - 11:04 am
Merck
Janux Therapeutics
R&D
T-cell engager
cancer
Special report: Twenty extraordinary women blazing trails in biopharma R&D — Covid-19 and beyond
Endpoints
Thu, 12/10/20 - 10:50 am
women
R&D
COVID-19
NASA-partnered Pluristem crashes to Earth as it axes leading therapy
Fierce Biotech
Thu, 12/10/20 - 10:48 am
Pluristem
clinical trials
R&D
critical limb ischemia
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation
Fierce Biotech
Mon, 12/7/20 - 10:37 am
AbCellera
Eli Lilly
R&D
Canada
COVID-19
antibodies
IPOs
Seer, a developer of protein analysis tools, prices upsized IPO at $19, above the range
Renaissance Capital
Fri, 12/4/20 - 10:56 am
R&D
IPOs
Seer
protein analysis
Arena Pharma's R&D lead quits 6 months into the job, replaced by Alder CMO
Fierce Biotech
Tue, 12/1/20 - 10:49 am
Arena Pharmaceuticals
R&D
Alder Biopharmaceuticals
Fancy a Black Friday R&D deal? Astellas has you covered
Fierce Biotech
Wed, 11/25/20 - 10:34 am
Astellas
R&D
Galapagos sells off Fidelta as CRO activities 'no longer fit with its strategy'
Fierce Biotech
Wed, 11/25/20 - 10:26 am
Galapagox
Fidelta
CROs
R&D

Pages